Breast cancer is molecularly classified based on three main biomarkers: oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Lee et al., 2019). This evidence concerns the gene ESR1 and breast cancer.